Atlas Genetics
- Portfolio Company: Atlas Genetics
- Date of Initial Investment: 21 July 2006
- Round of Financing: First Round
- Sector: Medical Diagostics
- SWVF Role: Co Investor
Atlas Genetics was formed in 2005 as a spin-out from the University of Bath where it is based, Atlas Genetics is working on an innovative platform that will analyse a clinical sample taken from blood, urine or saliva using a test cartridge inserted into a small portable instrument. An electronic tag developed by the company automatically indicates the presence of DNA from the pathogen causing serious infectious diseases including MRSA and Meningitis.
The technology developed by Atlas Genetics will allow hospitals and eventually GPs to perform such tests locally and make decisions about treatments within 30 minutes. Currently, hospitals and clinics can take up to 72 hours by which time patients may have become seriously ill.
Website: www.atlasgenetics.com
